Search

everythinglearnresearchcommunity

for

Search:↓

Environmental factors, hormones, nutrition, and stress all significantly affect skin health and aging.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

Prostate cancer prevention includes diet changes, supplements, and medications, with more answers expected soon.

Low-dose finasteride may cause lasting sexual dysfunction and suicidal thoughts in young men.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Some plant-based treatments can help with benign prostatic hyperplasia symptoms, but more research is needed to confirm their safety and effectiveness.

European guidelines recommend regular eye and ear exams, skin care, vitamin D supplements, and cautious use of medications for managing congenital ichthyoses.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Male pattern baldness is mostly inherited, involves many genes, and is linked to other traits like early puberty and strong bones.

Celiac disease can cause skin problems that may get better with a gluten-free diet.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

Some drugs may reduce prostatitis symptoms short-term with few side effects.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

The document suggests creating a validated score to diagnose Cushing's Syndrome and considers plasma steroid profiling as a simpler diagnostic method.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Low-dose oral minoxidil safely treats hair loss, with hypertrichosis as main side effect.

Spironolactone might help protect against severe lung problems in COVID-19 patients.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Young women with PCOS have a higher risk of high blood pressure and metabolic syndrome, but these risks may decrease after age 40.

SVF-enhanced adipose transplantation shows potential as a hair loss treatment.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Some growth factors, while important for normal body functions, can cause diseases when not regulated properly.